← Back to home

ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM

Clinical trials for ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New attack on hidden cancer cells could boost leukemia cure rates

Disease control Not yet recruiting

This study is for adults with a type of blood cancer called acute myeloid leukemia (AML) who have a small amount of leftover cancer after initial treatment. The goal is to test if adding newer drugs to a standard chemotherapy is better at wiping out these hidden cancer cells befo…

Matched conditions: ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM

Get alerted when new ACUTE MYELOID LEUKEMIA ARISING FROM PREVIOUS MYELOPROLIFERATIVE NEOPLASM trials appear

New attack on hidden cancer cells could boost leukemia cure rates